(Q35739073)

10 August 2017

1 reference

title

Complications of androgen deprivation therapy in men with prostate cancer (English)

1 reference

10 August 2017

1 reference

Allen C Chen

1

1 reference

10 August 2017

Daniel P Petrylak

series ordinal

2

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

published in

Current Oncology Reports

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

209-215

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-004-0051-0

10 August 2017

exact match

0 references

cites work

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-004-0051-0

Hormonal regulation of appetite and body mass in patients with advanced prostate cancer treated with combined androgen blockade

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-004-0051-0

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-004-0051-0

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

21 January 2018

1 reference

12 December 2020

Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study

1 reference

12 December 2020

Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons

1 reference

12 December 2020

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

1 reference

12 December 2020

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

12 December 2020

Regionally selective effects of gonadectomy on cortical catecholamine innervation in adult male rats are most disruptive to afferents in prefrontal cortex.

1 reference

12 December 2020

Fatigue in patients with prostate cancer receiving hormone therapy.

1 reference

12 December 2020

Transdermal clonidine for ameliorating post-orchiectomy hot flashes

1 reference

12 December 2020

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Androgen deprivation and cognition in prostate cancer

1 reference

12 December 2020

Effects of gonadectomy on immunoreactivity for choline acetyltransferase in the cortex, hippocampus, and basal forebrain of adult male rats

1 reference

12 December 2020

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

12 December 2020

Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.

1 reference

12 December 2020

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer

1 reference

12 December 2020

Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.

1 reference

12 December 2020

Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions

1 reference

12 December 2020

Intermittent androgen suppression for prostate cancer: rationale and clinical experience

1 reference

12 December 2020

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

1 reference

12 December 2020

Tamoxifen for flutamide/finasteride-induced gynecomastia

1 reference

12 December 2020

Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study

1 reference

12 December 2020

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

12 December 2020

The effects of androgens on the regulation of lipolysis in adipose precursor cells

1 reference

12 December 2020

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma

1 reference

12 December 2020

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer

1 reference

12 December 2020

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup

1 reference

12 December 2020

Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.

1 reference

12 December 2020

Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer--a randomized study.

1 reference

12 December 2020

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

1 reference

12 December 2020

Fracture risk following bilateral orchiectomy

1 reference

12 December 2020

The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer

1 reference

12 December 2020

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.

1 reference

12 December 2020

Effects of exercise on physiological and psychological variables in cancer survivors

1 reference

12 December 2020

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

12 December 2020

The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study

1 reference

12 December 2020

Transdermal estrogen in the treatment of hot flushes in men with prostate cancer

1 reference

12 December 2020

Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate

1 reference

12 December 2020

Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer

1 reference

12 December 2020

Gynecomastia in patients with prostate cancer: a review of treatment options

1 reference

12 December 2020

Endogenous sex hormones and cognitive function in older men.

1 reference

12 December 2020

Importance of serum hemoglobin in hormone refractory prostate cancer

1 reference

12 December 2020

Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes

1 reference

12 December 2020

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study

1 reference

12 December 2020

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Sex steroids and the construction and conservation of the adult skeleton

1 reference

12 December 2020

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study

1 reference

12 December 2020

Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study

1 reference

12 December 2020

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

1 reference

12 December 2020

Hot flushes and prostate cancer: pathogenesis and treatment

1 reference

12 December 2020

Testosterone influences spatial cognition in older men.

1 reference

12 December 2020

Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.

1 reference

12 December 2020

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

1 reference

12 December 2020

Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma

1 reference

12 December 2020

Sex steroids modify working memory

1 reference

12 December 2020

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

1 reference

12 December 2020

Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

1 reference

12 December 2020

10.1007/S11912-004-0051-0

Identifiers

DOI

1 reference

10 August 2017

1 reference